Heartland Group Holdings

HGH

The current Heartland Group Holdings (HGH) market capitalization is approximately NZ$1.10B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Heartland Group Holdings's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:53 PM Eastern Time

In the most recently reported quarter, Heartland Group Holdings (HGH) generated NZ$73.08M in revenue, representing a +17.06% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 2:57 AM Eastern Time

In the most recently reported fiscal year, Heartland Group Holdings (HGH) generated net income of NZ$38.81M, compared with NZ$74.55M in the prior fiscal year, representing a -47.94% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of NZ$87.57M. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 2:57 AM Eastern Time

Based on the latest available data, Heartland Group Holdings (HGH) is currently trading at a last twelve months (LTM) P/E ratio of 29.08x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 8:54 PM Eastern Time

Heartland Group Holdings (HGH) is currently scheduled to report its next earnings results on February 24, 2026. Earnings dates are subject to change and may be updated by the company with limited notice. Investors typically monitor upcoming earnings releases closely, as they can result in increased volatility depending on reported results, forward guidance, and management commentary. Last updated: December 31, 2025 at 11:53 PM Eastern Time

In the most recently reported quarter, Heartland Group Holdings (HGH) revenue was NZ$73.08M. Earnings per share (EPS) for the quarter were NZ$0.02. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 2:57 AM Eastern Time

Analyst assessments of whether Heartland Group Holdings (HGH) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: NZ$1.17Consensus price target: NZ$1.03Implied return: -11.68% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: January 1, 2026 at 8:54 PM Eastern Time

Based on the latest available analyst coverage, Heartland Group Holdings (HGH) currently carries a Hold consensus rating. Analysts' average HGH price target is NZ$1.03. Relative to the current share price of NZ$1.17, this suggests a potential price change of approximately -11.68%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 8:54 PM Eastern Time

Like other publicly traded stocks, Heartland Group Holdings (HGH) shares are bought and sold on stock exchanges such as NZSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Heartland Group Holdings (HGH) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add HGH to your watchlist.

Heartland Group Holdings trades under the ticker symbol HGH on the NZSE stock exchange. The ticker HGH is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

Heartland Group Holdings (HGH) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Heartland Group Holdings (HGH) stock peers based on overlapping products, services, and competitive dynamics:Port of Tauranga (POT)NZX (NZX)Vector (VCT)EnTie Commercial Bank (2849) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Heartland Group Holdings.